Kết quả tìm kiếm - Yufan Zhao
- Đang hiển thị 1 - 10 kết quả của 10
-
1
Reinforcement learning design for cancer clinical trials Bằng Yufan Zhao, Michael R. Kosorok, Donglin Zeng
Được phát hành 2009Artigo -
2
Reinforcement Learning Strategies for Clinical Trials in Nonsmall Cell Lung Cancer Bằng Yufan Zhao, Donglin Zeng, Mark A. Socinski, Michael R. Kosorok
Được phát hành 2011Artigo -
3
-
4
-
5
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma Bằng Geoffrey T. Gibney, Omid Hamid, Jose Lutzky, Anthony J. Olszanski, Tara C. Mitchell, Thomas F. Gajewski, Bartosz Chmielowski, Brent A. Hanks, Yufan Zhao, Robert Newton, Janet Maleski, Lance Leopold, Jeffrey S. Weber
Được phát hành 2019Artigo -
6
Preliminary results from a Phase I/II study of epacadostat (incb024360) in combination with pembrolizumab in patients with selected advanced cancers Bằng Tara C. Gangadhar, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Jason J. Luke, Ani Sarkis Balmanoukian, David R. Kaufman, Yufan Zhao, Janet Maleski, Lance Leopold, Thomas F. Gajewski
Được phát hành 2015Artigo -
7
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovar... Bằng Rebecca Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael J. Goodheart, В. А. Горбунова, C A Penning, Jack Shi, Xiangdong Liu, Robert Newton, Yufan Zhao, Janet Maleski, Lance Leopold, Russell J. Schilder
Được phát hành 2017Artigo -
8
Epacadostat plus pembrolizumab in patients with advanced melanoma and select solid tumors: Updated phase 1 results from ECHO-202/KEYNOTE-037 Bằng Tara C. Gangadhar, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Anthony J. Olszanski, Jason J. Luke, Ani Sarkis Balmanoukian, David R. Kaufman, Yufan Zhao, Janet Maleski, Michelle Jones, L. Leopold, Thomas F. Gajewski
Được phát hành 2016Artigo -
9
Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037) Bằng Tara C. Mitchell, Omid Hamid, David C. Smith, Todd M. Bauer, Jeffrey S. Wasser, Anthony J. Olszanski, Jason J. Luke, Ani Sarkis Balmanoukian, Emmett V. Schmidt, Yufan Zhao, Xiaohua Gong, Janet Maleski, Lance Leopold, Thomas F. Gajewski
Được phát hành 2018Artigo -
10
Naringenin suppresses epithelial ovarian cancer by inhibiting proliferation and modulating gut microbiota Bằng Caiji Lin, Zheng Zeng, Yiru Lin, Pengfei Wang, Danli Cao, Kaihong Xie, Yao Luo, Hao Yang, Jiaming Yang, Wenxue Wang, Lingjie Luo, Huihui Lin, Hang Chen, Yufan Zhao, Yongwei Shi, Zixiang Gao, Huidi Liu, Shu‐Lin Liu
Được phát hành 2022Artigo
Công cụ tìm kiếm:
Các môn học liên quan
Medicine
Internal medicine
Cancer
Adverse effect
Cancer research
Immunotherapy
Oncology
Tolerability
Biochemistry
Biology
Clinical trial
Pembrolizumab
Pharmacology
Artificial intelligence
Clinical endpoint
Computer science
Machine learning
Melanoma
Nausea
Ovarian cancer
Pathology
Rash
Reinforcement learning
Adjunctive treatment
Allopregnanolone
Alternative medicine
Amino acid
Antioxidant
Biotechnology
Botany